Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption
Biomolecules · 2025
DOI: 10.3390/biom15030340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jong Su Hwang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Methamphetamine, rho-Associated Kinases, Signal Transduction. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, The Ministry of Science and ICT (MSIT), Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education.
Abstract (Originalsprache)
Methamphetamine (METH) is a powerful addictive psychostimulant that gives rise to severe abusers worldwide. While many studies have reported on the neurotoxicity of METH, blood–brain barrier (BBB) dysfunction has recently attracted attention as an essential target in METH-induced pathological changes in the brain. However, its mechanism has not been fully understood. We found that METH increased paracellular permeability and decreased vascular integrity through FITC–dextran and trans-endothelial electrical resistance (TEER) assay in primary human brain endothelial cells (HBMECs). Also, redistribution of tight junction proteins (zonula occluden-1 and claudin-5) and reorganization of F-actin cytoskeleton were observed in METH-exposed HBMECs. To determine the mechanism of METH-induced BBB disruption, the RhoA/ROCK signaling pathway was examined in METH-treated HBMECs. METH-activated RhoA, followed by an increase in the phosphorylation of downstream effectors, myosin light chain (MLC) and cofilin, occurs in HBMECs. Pretreatment with ROCK inhibitors Y-27632 and fasudil reduced the METH-induced increase in phosphorylation of MLC and cofilin, preventing METH-induced redistribution of junction proteins and F-actin cytoskeletal reorganization. Moreover, METH-induced BBB leakage was alleviated by ROCK inhibitors in vitro and in vivo. Taken together, these results suggest that METH induces BBB dysfunction by activating the RhoA/ROCK signaling pathway, which results in the redistribution of junction proteins via F-actin cytoskeletal reorganization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
ORCID-Profile: Tam Thuy Lu Vo, Eunyoung Ha, Ji Hae Seo
Förderung
- National Research Foundation of Korea
- The Ministry of Science and ICT (MSIT)
- Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education
- Korean Government (MSIT)
Zitieren
APA
Hwang, J. S., Vo, T. T. L., Kim, M., Cha, E. H., Mun, K. C., Ha, E., & Seo, J. H. (2025). Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption. Biomolecules. https://doi.org/10.3390/biom15030340
Vancouver
Hwang JS, Vo TTL, Kim M, Cha EH, Mun KC, Ha E, et al. Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption. Biomolecules. 2025. doi:10.3390/biom15030340
BibTeX
@article{Hwang2025,
author = {Hwang, Jong Su and Vo, Tam Thuy Lu and Kim, Mikyung and Cha, Eun Hye and Mun, Kyo Cheol and Ha, Eunyoung and Seo, Ji Hae},
title = {Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15030340}
}
EUVIMED